ArticlePDF Available

Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia

Authors:

Abstract and Figures

Aberrant dopamine function in the dorsal striatum and aberrant intrinsic functional connectivity (iFC) between distinct cortical networks and thalamic nuclei are among the most consistent large-scale brain imaging findings in schizophrenia. A pathophysiological link between these two alterations is suggested by theoretical models based on striatal dopamine’s topographic modulation of cortico-thalamic connectivity within cortico-basal-ganglia-thalamic circuits. We hypothesized that aberrant striatal dopamine links topographically with aberrant cortico-thalamic iFC, i.e. aberrant associative striatum dopamine is associated with aberrant iFC between the salience network and thalamus, and aberrant sensorimotor striatum dopamine with aberrant iFC between the auditory-sensorimotor network and thalamus. Nineteen patients with schizophrenia during remission of psychotic symptoms and 19 age- and sex-comparable control subjects underwent simultaneous fluorodihydroxyphenyl-l-alanine PET (18F-DOPA-PET) and resting state functional MRI (rs-fMRI). The influx constant kicer based on 18F-DOPA-PET was used to measure striatal dopamine synthesis capacity; correlation coefficients between rs-fMRI time series of cortical networks and thalamic regions of interest were used to measure iFC. In the salience network-centred system, patients had reduced associative striatum dopamine synthesis capacity, which correlated positively with decreased salience network-mediodorsal-thalamus iFC. This correlation was present in both patients and healthy controls. In the auditory-sensorimotor network-centred system, patients had reduced sensorimotor striatum dopamine synthesis capacity, which correlated positively with increased auditory-sensorimotor network-ventrolateral-thalamus iFC. This correlation was present in patients only. Results demonstrate that reduced striatal dopamine synthesis capacity links topographically with cortico-thalamic intrinsic dysconnectivity in schizophrenia. Data suggest that aberrant striatal dopamine and cortico-thalamic dysconnectivity are pathophysiologically related within dopamine-modulated cortico-basal ganglia-thalamic circuits in schizophrenia.
Content may be subject to copyright.
Aberrant striatal dopamine links
topographically with cortico-thalamic
dysconnectivity in schizophrenia
Mihai Avram,
1,2,3,
Felix Brandl,
1,2,4,
Franziska Knolle,
1,2,5
Jorge Cabello,
3
Claudia Leucht,
4
Martin Scherr,
4
Mona Mustafa,
3
Nikolaos Koutsouleris,
6,7
Stefan Leucht,
4,8
Sibylle Ziegler
3,9
and Christian Sorg
1,2,4
These authors contributed equally to this work.
Aberrant dopamine function in the dorsal striatum and aberrant intrinsic functional connectivity (iFC) between distinct cortical net-
works and thalamic nuclei are among the most consistent large-scale brain imaging findings in schizophrenia. A pathophysiological
link between these two alterations is suggested by theoretical models based on striatal dopamine’s topographic modulation of cor-
tico-thalamic connectivity within cortico-basal-ganglia-thalamic circuits. We hypothesized that aberrant striatal dopamine links
topographically with aberrant cortico-thalamic iFC, i.e. aberrant associative striatum dopamine is associated with aberrant iFC
between the salience network and thalamus, and aberrant sensorimotor striatum dopamine with aberrant iFC between the audi-
tory-sensorimotor network and thalamus. Nineteen patients with schizophrenia during remission of psychotic symptoms and 19
age- and sex-comparable control subjects underwent simultaneous fluorodihydroxyphenyl-L-alanine PET (
18
F-DOPA-PET) and
resting state functional MRI (rs-fMRI). The influx constant k
icer
based on
18
F-DOPA-PET was used to measure striatal dopamine
synthesis capacity; correlation coefficients between rs-fMRI time series of cortical networks and thalamic regions of interest were
used to measure iFC. In the salience network-centred system, patients had reduced associative striatum dopamine synthesis cap-
acity, which correlated positively with decreased salience network-mediodorsal-thalamus iFC. This correlation was present in both
patients and healthy controls. In the auditory-sensorimotor network-centred system, patients had reduced sensorimotor striatum
dopamine synthesis capacity, which correlated positively with increased auditory-sensorimotor network-ventrolateral-thalamus
iFC. This correlation was present in patients only. Results demonstrate that reduced striatal dopamine synthesis capacity links
topographically with cortico-thalamic intrinsic dysconnectivity in schizophrenia. Data suggest that aberrant striatal dopamine and
cortico-thalamic dysconnectivity are pathophysiologically related within dopamine-modulated cortico-basal ganglia-thalamic cir-
cuits in schizophrenia.
1 Department of Neuroradiology, Klinikum rechts der Isar, Technische Universita¨t Mu¨ nchen, Munich, 81675, Germany
2 TUM-NIC Neuroimaging Center, Klinikum rechts der Isar, Technische Universita¨t Mu¨nchen, Munich, 81675, Germany
3 Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universita¨t Mu¨ nchen, Munich, 81675, Germany
4 Department of Psychiatry, Klinikum rechts der Isar, Technische Universita¨t Mu¨nchen, Munich, 81675, Germany
5 Department of Psychiatry, University of Cambridge, Cambridge, UK
6 Department of Psychiatry, University Hospital, LMU Munich, Munich, 81377, Germany
7 Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London SE5 8AB, UK
8 Department of Psychosis studies, King’s College London, UK
9 Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, 81377, Germany
Correspondence to: Mihai Avram
Department of Neuroradiology, Klinikum rechts der Isar, Technische Universita¨t Mu¨ nchen
Received April 23, 2020. Revised June 30, 2020. Accepted July 16, 2020. Advance access publication November 6, 2020
V
CThe Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved.
For permissions, please email: journals.permissions@oup.com
doi:10.1093/brain/awaa296 BRAIN 2020: 143; 3495–3505 |3495
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
Munich, 81675, Germany
E-mail: mihai.avram@tum.de
Keyword:
18
F-DOPA-PET; striatal dopamine synthesis capacity; resting-state fMRI; cortico-thalamic dysconnectivity
Abbreviations: ASM = auditory-sensorimotor network; CSPTC = cortico-striato-pallido-thalamo-cortical; DSC = dopamine syn-
thesis capacity; FD = framewise displacement; iFC = intrinsic functional connectivity; rs-fMRI = resting state functional MRI; SAL
= salience network
Introduction
Both aberrant dopamine transmission in the striatum
(Hietala et al.,1999;Howes et al.,2013;Jauhar et al.,
2017;Avram et al.,2019) and aberrant intrinsic functional
connectivity (iFC) between distinct cortical networks and
thalamic nuclei (Woodward et al.,2012;Anticevic et al.,
2015;Tu et al.,2015;Woodward and Heckers, 2016;
Avram et al.,2018) are among the most consistent large-
scale in vivo brain imaging findings in schizophrenia.
Concerning dopamine transmission, distinct aspects are
aberrant in schizophrenia, particularly presynaptic striatal
dopamine synthesis capacity (DSC) and dopamine release
(Hietala et al.,1999;Abi-Dargham et al.,2000,2009;
Kegeles et al., 2010;Howes et al.,2013;Jauhar et al.,2017;
Avram et al.,2019). The most consistent finding is aberrant
DSC in the ‘associative striatum’, with DSC being measured
by 6-
18
F-fluoro-3,4-dihydoxylphenyl-L-alanine PET (
18
F-
DOPA-PET) (McCutcheon et al.,2018,2020); the associa-
tive striatum mainly consists of the caudate nucleus; other
striatal subregions are the sensorimotor striatum (mostly
covering putamen) and the limbic striatum (mainly compris-
ing nucleus accumbens). In patients with schizophrenia and
current psychotic symptoms, striatal DSC is typically
increased (Hietala et al., 1999;Howes et al.,2009,2013;
Jauhar et al.,2017,2018). There is evidence, however, that
striatal DSC is not increased in patients with only mild
psychotic symptoms (Kim et al.,2017), and our group has
recently found decreased striatal DSC in patients with
schizophrenia during psychotic remission (Avram et al.,
2019). These last findings might reflect an effect of disorder
state (i.e. increased DSC during psychosis versus decreased
DSC during psychotic remission) and/or antipsychotic medi-
cation (Grunder and Cumming, 2019).
Concerning cortico-thalamic iFC, dysconnectivity has been
observed in at-risk, first-episode, and chronic patients with
schizophrenia as well as first-degree relatives of patients
(Woodward et al.,2012;Anticevic et al.,2015;Lui et al.,
2015;Woodward and Heckers, 2016;Avram et al.,2018;
Brandl et al., 2019). Cortico-thalamic dysconnectivity
reflects aberrant coherence of infra-slow (50.1 Hz) fluctua-
tions of ongoing brain activity between distal regions, typic-
ally measured by correlated blood oxygenation fluctuations
in resting state functional MRI (rs-fMRI) (Biswal et al.,
1995). Brain-wide ongoing activity is organized by sets
of distinct iFC patterns, known as intrinsic brain
networks, such as the salience network (SAL) covering
cingulo-opercular-insular-mediofrontal cortices, or the audi-
tory-sensorimotor network (ASM) covering somatosensory/
motor and temporal cortices (Fox and Raichle, 2007;Yeo
et al., 2011). The most robust findings of aberrant iFC in
schizophrenia are, on the one hand, decreased iFC (‘hypo-
connectivity’) between frontal cortices of SAL and anterior/
mediodorsal thalamus, and on the other hand, increased iFC
(‘hyperconnectivity’) between primary auditory-sensorimotor
cortices of ASM and posterior/ventrolateral thalamus
(Woodward et al.,2012;Anticevic et al.,2015;Lui et al.,
2015;Woodward and Heckers, 2016;Avram et al.,2018;
Brandl et al.,2019).
It is, however, unclear whether aberrant striatal DSC and
altered cortico-thalamic iFC are related in schizophrenia.
Such a relationship has long been suggested based on ana-
tomical and physiological considerations (Swerdlow and
Koob, 1987), and partially explored via
18
F-deoxyglucose
PET in patients with schizophrenia (Wu et al.,1990): cor-
tico-thalamic iFC is part of largely parallel, topographically
organized cortico-striato-pallido-thalamo-cortical circuits,
which are modulated by midbrain dopaminergic neurons
projecting into the striatum (Fig. 1,top)(Alexander et al.,
1986;Haber, 2003;Hikosaka et al.,2006). In particular,
SAL-anterior/mediodorsal thalamus connectivity extends
topographically to dorsomedial parts of basal ganglia cir-
cuits (including associative striatum and corresponding mid-
brain dopaminergic projections)—we call it the SAL-centred
system. More posterior connections between ASM and pos-
terior/ventrolateral thalamus integrate dorsolateral parts of
the basal ganglia (including sensorimotor striatum and cor-
responding midbrain dopaminergic projections)—we call it
the ASM-centred system (Alcauter et al.,2014;Delevich
et al.,2015;Peters et al.,2016;Avram et al.,2018). In sup-
port of such relations, a recent study combining
18
F-DOPA-
PET and rs-fMRI investigated associations between striatal
DSC and iFC of different intrinsic brain networks, including
SAL and ASM, in healthy subjects (McCutcheon et al.,
2019). While no significant associations were reported be-
tween striatal DSC and iFC of the ASM, within-SAL-iFC
correlated significantly with striatal DSC (including associa-
tive striatum) (for similar findings see Cole et al.,2013;
Berry et al.,2018).
Thus, the question arises whether such topographic rela-
tionships can also be expected between aberrant striatal
DSC and aberrant cortico-thalamic iFC in schizophrenia.
To address this question, we carried out simultaneous
18
F-DOPA-PET and rs-fMRI using a hybrid PET/MRI
3496 |BRAIN 2020: 143; 3495–3505 M. Avram et al.
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
scanner in healthy controls and patients with established
schizophrenia, i.e. with more than one psychotic episode.
We focused on patients during remission of psychotic symp-
toms to reduce heterogeneity of psychotic symptoms, which
seem to be linked with striatal DSC. We hypothesized specif-
ically that SAL-thalamic iFC is decreased and associated
with decreased associative striatum DSC, while ASM-thal-
amic iFC is increased and associated with decreased sensori-
motor striatum DSC (Fig. 1,bottom).
Materials and methods
Participants
Twenty-three patients with schizophrenia and 24 age- and sex-
comparable healthy controls participated in the study. PET data
from this sample have been used in a previous study, which
demonstrated decreased striatal DSC in schizophrenia during re-
mission of psychotic symptoms (Avram et al., 2019). Because of
excessive head motion during rs-fMRI, several subjects were
excluded, with 19 subjects remaining in each group for further
analyses (see below and Table 1).
Patients had established schizophrenia according to DSM-IV
criteria, were in symptomatic remission of psychotic symptoms
(based on severity criteria by Andreasen et al.,2005) during the
study, and were all treated with antipsychotic medication
(Supplementary Table 1). The diagnosis of schizophrenia was
supported by the Structured Clinical Interview for DSM-IV
(First et al.,2002). Substance abuse, except nicotine, was an ex-
clusion criterion in both groups. Participants gave written
informed consent after receiving a complete description of the
study, which was approved by the Ethics Review Board of the
Technical University of Munich. Approval to administer radio-
tracers was obtained from the Administration of Radioactive
Substances (Bundesamt fu¨ r Strahlenschutz), Germany. For a
detailed participant description, including inclusion and exclu-
sion criteria, see the online Supplementary material or Avram
et al. (2019).
18
F-DOPA-PET data acquisition and preprocessing
18
F-DOPA-PET and MRI data were acquired simultaneously
with a hybrid whole-body mMR Biograph PET/MRI scanner
(Siemens-Healthineers). We used
18
F-DOPA-PET to measure the
influx constant k
icer
, a quantitative measure reflecting DSC, in
a voxel-wise manner with Gjedde–Patlak linear graphical
Figure 1 Research background and hypothesis. To p : Schematic depiction of cortico-thalamic connectivity and striatal circuits embedded in
larger CSPTC circuits, following Haber and McFarland (2001). Colour gradients across cortical and subcortical regions indicate the topographic,
parallel, but continuous organization of circuits, from which we derived the SAL-centred and ASM-centred systems. Note that these circuits re-
ceive dopaminergic modulation from ventral tegmentum and substantia nigra, pars compacta. Left: The SAL-centred system is depicted as an or-
ange ellipse. Reduced associative striatum DSC as well as reduced iFC between SAL (derived from Yeo et al., 2011) and the thalamic cluster that
was hypoconnected with SAL in our previous study (Avram et al., 2018) are graphically depicted (blue arrows). The grey arrow reflects our hy-
pothesis. Right: The ASM-centred system is depicted as a blue ellipse. Reduced sensorimotor striatum DSC as well as increased iFC between
ASM (derived from Ye o et al., 2011) and the thalamic cluster that was hyperconnected with ASM in our previous study (Avram et al., 2018)are
graphically depicted (blue and red arrows, respectively). The grey arrow reflects our hypothesis.
Dopamine and brain connectivity in schizophrenia BRAIN 2020: 143; 3495–3505 |3497
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
analysis (Patlak et al.,1983), and compared averaged striatal
subdivisions’ k
icer
across groups with two-sample t-tests. The
same approach was was as in our previous study (Avram et al.,
2019)(Supplementary material).
Resting state functional MRI data acquisition and
preprocessing
Before rs-fMRI, participants were instructed to close their eyes
and to remain still, but stay awake. Rs-fMRI began simultan-
eously with the PET scan and lasted 20 min 8 s. Six hundred
volumes were acquired using T
2
-weighted echo-planar-imaging,
consisting of 35 axial slices (slice thickness = 3.0mm), field of
view (FoV) = 192 192 mm matrix (3.0 mm 3.0 mm in-
plane resolution), 90flip angle, repetition time = 2000 ms, and
echo time = 30 ms. Anatomical T
1
-weighted structural images
were obtained using gradient-echo imaging [repetition time/echo
time/flip angle: 2.300 ms/2.98 ms/9; 160 slices (gap 0.5 mm)
covering the whole brain; FoV: 256 mm; matrix size:
256 256; voxel size: 1.0 1.0 1.0 mm
3
].
MRI data were preprocessed with the Configurable Pipeline
for the Analysis of Connectomes (C-PAC, http://fcp-indi.github.
com). After removing the first five volumes, preprocessing
included image realignment, motion correction, scrubbing, in-
tensity normalization, nuisance signal regression [scanner drift,
head motion signals, and component-based noise correction
(Compcor) to remove physiological noise] (Behzadi et al.,
2007), bandpass filtering (0.01–0.1 Hz), registration to anatom-
ical space and normalization to MNI 2 mm
3
space with FSL
FLIRT/FNIRT. The Friston 24-parameter model was used to re-
gress out head motion effects (i.e. six head motion parameters,
six head motion parameters one time point before, and the 12
corresponding squared items). Because of excessive head mo-
tion, estimated with mean framewise displacement (FD) (Power
et al.,2012,2014), five healthy controls and four patients were
excluded (FD 40.2 mm). The remaining participants (19 per
group) did not differ in mean FD (P= 0.49), percentage of
frames deleted (P= 0.71), age (P= 0.27), and injected radioli-
gand dose (P= 0.91), as shown by t-tests, or sex (P= 0.73), as
shown by chi-squared test (Table 1).
We investigated cortico-thalamic iFC for SAL and ASM, re-
spectively, with seed-based iFC analysis. Cortical seeds were
derived from the 17-network cortical parcellation of Yeo et al.
(2011). The iFC analysis was restricted to the thalamus, with
thalamic target regions of interest based on thalamic clusters
from our previous study of SAL-/ASM-hypo-/hyperconnectivity
in a completely distinct, independent sample of patients with
schizophrenia (Avram et al.,2018). For SAL-iFC, we masked
the thalamus with the group-distinct cluster we previously
reported to be hypoconnected with SAL in patients (mainly cov-
ering mediodorsal and ventral anterior nuclei), and for ASM-
iFC, we used the analogous cluster previously reported to be
hyperconnected with ASM in patients (mainly covering ventral
and posterior thalamic nuclei). Correlating the time courses of
these seeds and target regions of interest, we generated z-maps
reflecting SAL-thalamic and ASM-thalamic iFC. Subsequently,
we extracted voxel-wise iFC values from the target regions of
interest, averaged them, and performed two-sample t-tests to
compare the resulting region of interest-wise iFC values between
groups.
Statistical analyses
Relationship between striatal dopamine synthesis
capacity and cortico-thalamic intrinsic functional
connectivity
To elucidate the physiological background of the relationship
between striatal DSC and cortico-thalamic iFC and to replicate
previous findings (McCutcheon et al.,2019), we initially investi-
gated this relationship in healthy controls, thereby bypassing
possible effects of the disorder and/or antipsychotic medication.
We used partial correlation analyses with age, sex, and head
motion (FD) as covariates of no interest to investigate relation-
ships within systems (i.e. associative striatum DSC and SAL-
thalamic iFC, and sensorimotor striatum DSC and ASM-thal-
amic iFC, respectively).
Next, to test our main hypothesis of a topographic associ-
ation between altered striatal DSC and cortico-thalamic dyscon-
nectivity in schizophrenia, we performed partial correlation
analyses in patients, with age, sex, FD, and chlorpromazine
equivalents (CPZ) as covariates of no interest.
Finally, we tested whether associations between striatal DSC
and cortico-thalamic iFC differed between patients and controls.
Table 1 Participant demographics and clinical-neuropsychological scores
Patients with schizophrenia Healthy controls P-value
Mean ±SD Mean ±SD
n19 19
Age, years 41.1 ±12.17 36.84 ±11.5 0.27
Females/males 7/12 6/13 0.73
FD, mm 0.12 ±0.03 0.11 ±0.03 0.49
Injected radioactivity, MBq 141.57 ±17.42 142.31 ±26.1 0.91
Illness duration, years 13.47 ±9NANA
Chlorpromazine equivalents, mg/day 492.15 ±380.04 NA NA
PANSS, a.u.
Positive 11.36 ±3.53 NA NA
Negative 14.31 ±6.36 NA NA
General 26.73 ±7.42 NA NA
Total 51.42 ±13.61 NA NA
Age, FD, injected radioactivity, and PANSS scores were compared with two-sample t-tests; gender was compared using chi-squared test. a.u. = arbitrary units; NA = not applicable;
PANSS = Positive and Negative Syndrome Scale; SD = standard deviation.
3498 |BRAIN 2020: 143; 3495–3505 M. Avram et al.
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
To this end, we performed a multiple regression analysis with
cortico-thalamic iFC as dependent variable and striatal DSC,
group, and the interaction DSC group (our outcome of inter-
est) as independent variables, as well as age, sex, FD, and CPZ
as covariates of no interest.
Control analyses
We conducted several control analyses for potential confound-
ing effects such as choice of thalamic regions of interest for cor-
tico-thalamic iFC, motion-induced artefacts, or current
medication. Detailed descriptions of these analyses can be found
in the Supplementary material.
Data availability
The data that support the findings of this study are available on
request from the corresponding author. The data are not public-
ly available due to their containing information that could com-
promise the privacy of research participants.
Results
SAL-centred system
Associative striatum DSC and SAL-thalamic
intrinsic functional connectivity are decreased in
patients
Averaged associative striatum DSC values were significantly
reduced (P= 0.004) in patients (mean kcer
i=0.0129±0.001
min
–1
) compared to healthy controls (mean k
icer
=
0.0144 ±0.001 min
–1
)(Fig. 2A). Patients had reduced
(P= 0.04) SAL-mediodorsal/ventral-anterior-thalamus iFC
(mean z=0.07±0.04) compared to controls (mean
z=0.10±0.05) (Fig. 2B).Controlanalysesdidnotfindany
confounding effects of head motion (i.e. FD) or current
medication (i.e. CPZ) on group differences in associative stri-
atum DSC and SAL-thalamic iFC, respectively, suggesting
that decreased DSC and iFC values did not depend on mo-
tion artefacts or current medication (Supplementary
material).
Relationship between associative striatum DSC and
SAL-thalamic intrinsic functional connectivity in
controls
To elucidate the physiological background of the association
between associative striatum DSC (k
icer
) and SAL-thalamic
iFC (z-values), we studied this relationship in healthy con-
trols only, using partial correlation analysis with age, sex,
and FD as covariates of no interest. We found an ‘at trend
to significant’ correlation between associative striatum DSC
and SAL-thalamic iFC (r=0.38,P=0.07)(Fig. 2C). This re-
sult is in line with previous findings (McCutcheon et al.,
2019) and supports the idea of a physiological link between
striatal DSC and cortico-thalamic iFC in the SAL-centred
system.
Decreased associative striatum DSC is associated
with decreased SAL-thalamic intrinsic functional
connectivity in patients
To test our study’s hypothesis for the SAL-centred system,
we investigated the association between reduced associative
striatum DSC and SAL-thalamic iFC in patients with schizo-
phrenia via partial correlation analysis with age, sex, FD,
and CPZ as covariates of no interest. Similar to healthy con-
trols, we found a significant positive correlation between as-
sociative striatum DSC and SAL-thalamic iFC in patients
(r=0.51, P=0.02) (Fig. 2C). This association was not con-
founded by the choice of thalamic region of interest
(Supplementary material).
Associative striatum DSC and SAL-thalamic
intrinsic functional connectivity are related both in
patients and controls
Finally, we investigated whether schizophrenia significantly
modulates the relation between DSC and iFC in the SAL-
centred system. In more detail, we performed a multiple re-
gression analysis with interaction, using SAL-thalamic iFC
as dependent variable and associative striatum DSC, group,
and the interaction DSC group as independent variables
as well as age, sex, FD, and CPZ as covariates of no interest.
No significant interaction effect of ‘group associative stri-
atum DSC’ was found on SAL-thalamic iFC (P=0.8), indi-
cating that the positive correlation between striatal DSC and
cortico-thalamic iFC in the SAL-centred system reflects a
continuum across healthy controls and patients rather than
a group-specific characteristic. To estimate the effects of the
various covariates of no interest (age, sex, FD, CPZ) on the
associations between striatal DSC and cortico-thalamic iFC,
we computed several models (Supplementary Tables 2–4).
ASM-centred system
Sensorimotor striatum DSC is decreased and ASM-
thalamic intrinsic functional connectivity is
increased in patients
Averaged sensorimotor striatum DSC was significantly
reduced (P= 0.02) in patients (mean k
icer
=0.0135±0.002
min
–1
) compared to controls (mean k
icer
=0.0156±0.002
min
–1
)(Fig. 3A). Patients had increased (P=0.02)
ASM-ventral/posterior-thalamus iFC (mean z=0.05±0.035)
compared to controls (mean z=0.015±0.05) (Fig. 3B).
Control analyses did not find any confounding effects of
head motion (i.e. FD) or current medication (i.e. CPZ) on
group differences in sensorimotor striatal DSC and ASM-
thalamic iFC, respectively, suggesting that decreased DSC
and iFC values did not depend on head motion artefacts or
current medication (Supplementary material).
Relationship between sensorimotor striatum DSC
and ASM-thalamic intrinsic functional connectivity
in controls
To elucidate the physiological background of the association
between decreased sensorimotor striatum DSC (k
icer
)and
Dopamine and brain connectivity in schizophrenia BRAIN 2020: 143; 3495–3505 |3499
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
increased ASM-thalamic iFC (z-values), we first studied this
relationship in healthy controls only, via partial correlation
analysis with age, sex, and FD as covariates of no interest.
In line with previous findings (McCutcheon et al.,2019), the
association was not significant (r=–0.23,P=0.18)
(Fig. 3C), suggesting that under physiological conditions, a
relationship between sensorimotor striatum DSC and ASM-
thalamic iFC is unlikely.
Decreased sensorimotor striatum DSC is associated
with increased ASM-thalamic intrinsic functional
connectivity in patients
To test our study’s hypothesis for the ASM-centred system,
we investigated the association between sensorimotor stri-
atum DSC and ASM-thalamic iFC in patients with schizo-
phrenia via partial correlation analysis with age, sex, FD,
and CPZ as covariates of no interest. In contrast to healthy
controls, we found a significant positive correlation between
sensorimotor striatum DSC and ASM-thalamic iFC in
patients (r=0.54, P=0.01) (Fig. 3C). This association was
not confounded by the choice of thalamic regions of interest
(Supplementary material).
Sensorimotor striatum DSC and ASM-thalamic
intrinsic functional connectivity are related only in
patients
Finally, we tested whether schizophrenia significantly modu-
lates the relationship between DSC and iFC in the ASM-cen-
tred system. We performed a multiple regression analysis
with interaction with ASM-thalamic iFC as dependent vari-
able and sensorimotor striatum DSC, group, and the inter-
action DSC group as independent variables, as well as
age, sex, FD, and CPZ as covariates of no interest. The
interaction ‘group sensorimotor striatum DSC’ was sig-
nificant (P= 0.04), suggesting that—for the ASM-centred
system—sensorimotor striatum DSC and ASM-thalamic iFC
are related in patients only.
Figure 2 Results for the salience network-centred system. (A)Top left: One-sample t-test parametric map of k
icer
(indicating DSC) in the
associative striatum (AST), based on
18
F-DOPA-PET and graphical Patlak analysis. Top right: Associative striatum region of interest from Oxford-
GSK-Imanova atlas. Bottom: Box plots depicting significant group differences in associative striatum DSC (averaged across the region of interest),
measured with a two-sample t-test. (B)Top left: Template of salience network (SAL) derived from Ye o et al. (2011).Top right: Thalamic region of
interest reflecting hypoconnectivity with SAL, derived from our previous study (Avram et al., 2018). Bottom: Box plots depicting group differences
in SAL-thalamic iFC (averaged across the thalamic region of interest), measured with a two-sample t-test. (C) Partial correlations (age, sex, FD,
and CPZ as covariates of no interest) between averaged associative striatum DSC and averaged SAL-thalamic iFC in patients with schizophrenia
(red line and dots) and healthy controls (blue line and dots). The interaction between group and associative striatum DSC is based on a multiple
regression analysis with SAL-thalamic iFC as dependent variable and associative striatum DSC, group, and the interaction DSC group as inde-
pendent variables (age, sex, FD, and CPZ as covariates of no interest). k
icer
= steady-state uptake rate constant of
18
F-DOPA-PET relative to
cerebellum; HC = healthy controls; SCZ = patients with schizophrenia.
3500 |BRAIN 2020: 143; 3495–3505 M. Avram et al.
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
Discussion
Using simultaneous
18
F-DOPA-PET and rs-fMRI in patients
with schizophrenia during remission of psychotic symptoms,
we tested the hypothesis that reduced striatal dopamine links
topographically with cortico-thalamic dysconnectivity. We
found, on the one hand, for the SAL-centred system that
decreased DSC in the associative striatum was associated
with patients’ decreased SAL-thalamic iFC. On the other
hand, in the ASM-centred system, decreased sensorimotor
striatum DSC was associated with increased ASM-thalamic
iFC in patients. These findings demonstrate—to the best of
our knowledge for the first time—that aberrant striatal
dopamine links topographically with cortico-thalamic dys-
connectivity in schizophrenia. Data suggest that striatal
dopamine dysfunction and cortico-thalamic dysconnectivity
are pathophysiologically related.
SAL-centred system
Reduced associative striatum DSC links with
reduced SAL-thalamic intrinsic functional
connectivity
We found a trend for a positive correlation between associa-
tive striatum DSC and SAL-thalamic iFC in healthy controls.
Although only at-trend significant, this result is in line with
recent findings reported by McCutcheon et al. (2019),who
found a positive correlation between associative striatum
DSC and within-SAL iFC in healthy subjects. These observa-
tions suggest a physiological basis for the link between asso-
ciative striatum DSC and SAL-iFC.
Compared to healthy controls, patients with schizophre-
nia during psychotic remission had both reduced associa-
tive striatum DSC and reduced SAL-thalamic iFC, as
previously reported (Woodward and Heckers, 2016;
Avram et al., 2018,2019;Brandl et al., 2019). Critically,
Figure 3 Results for the auditory-sensorimotor network-centred system. (A)Top left: One-sample t-test parametric map of kcer
i
(DSC) in the sensorimotor striatum. Top right: Sensorimotor striatum region of interest from Oxford-GSK-Imanova atlas. Bottom: Box blots
depicting significant group differences in sensorimotor striatum DSC, measured with a two-sample t-test on average DSC values. (B)Top left:
Template of auditory-sensorimotor network (ASM) derived from Ye o et al. (2011) Top right: Thalamic region of interest reflecting hyperconnectiv-
ity with ASM, derived from our previous study (Avram et al., 2018). Bottom: Box blots depicting group differences in ASM-thalamic iFC, measured
with a two-sample t-test on average iFC values. (C) Partial correlations (age, sex, FD, and CPZ as covariates of no interest) between averaged
sensorimotor striatum (SMST) DSC and averaged ASM-thalamic iFC in patients with schizophrenia (red line and dots) and healthy controls (blue
line and dots). The interaction between group and sensorimotor striatum DSC is based on a multiple regression analysis with ASM-thalamic iFC
as dependent variable and sensorimotor striatum DSC, group, and the interaction DSC group as independent variables (age, sex, FD, and CPZ
as covariates of no interest). k
icer
= steady-state uptake rate constant of
18
F-DOPA-PET relative to cerebellum; HC = healthy controls; SCZ =
patients with schizophrenia.
Dopamine and brain connectivity in schizophrenia BRAIN 2020: 143; 3495–3505 |3501
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
we found that the two measures correlated significantly in
patients. Furthermore, a multiple regression analysis dem-
onstrated that the association between associative stri-
atum DSC and SAL-thalamic iFC was not distinct for the
two groups as the interaction effect of group and associa-
tive striatum DSC on SAL-thalamic iFC was not signifi-
cant. This suggests that the association between
associative striatum DSC and SAL-thalamic iFC reflects a
continuum across subjects rather than a characteristic that
is specific for schizophrenia. Furthermore, this finding is
congruent with general evidence that the dopaminergically
modulated basal ganglia interact with cortico-thalamic
connectivity (Carlsson et al.,2001;Haber and Calzavara,
2009;Bell and Shine, 2016) through parallel, topograph-
ically organized cortico-striato-pallido-thalamo-cortical
circuits (CSPTC) (Hikosaka et al.,2014;Grillner and
Robertson, 2016;Shepherd and Grillner, 2018).
Particularly, associative cortices including frontal/SAL
regions (i.e. opercular-insula, dorsal anterior cingulate)
form, together with the associative striatum and medio-
dorsal nucleus, parts of the associative CSPTC circuit
(Alexander et al., 1986;Parent and Hazrati, 1995). The
circuit is modulated by dopaminergic projections from
substantia nigra pars compacta, which projects topo-
graphically to cortical and subcortical areas, including
dorsal striatum and mediodorsal nucleus (Joel and
Weiner, 2000;McFarland and Haber, 2002;Haber and
Knutson, 2010;Varela, 2014). In such a framework,
changes in both associative striatum DSC and SAL-thal-
amic iFC might contribute to CSPTC circuit aberrances.
Below, we discuss which of both changes, reduced striatal
DSC or SAL-thalamic iFC, might be primary, i.e. drive
changes in the other measure.
ASN-centred system
Reduced sensorimotor striatum DSC links with
increased ASM-thalamic intrinsic functional
connectivity
Sensorimotor striatum DSC and ASM-thalamic iFC were
not significantly correlated in healthy controls, which indi-
cates that under physiological conditions, a relationship be-
tween the two measures is unlikely. This result is in line with
a previous report in which a significant association between
striatal DSC and iFC of the sensorimotor network was ab-
sent (McCutcheon et al.,2019).
Compared to healthy controls, patients had decreased sen-
sorimotor striatum DSC and increased ASM-thalamic iFC,
in line with previous findings (Woodward et al.,2012;
Avram et al.,2018,2019;Brandl et al.,2019). Furthermore,
supporting our hypothesis, the two measures were positively
correlated. A multiple regression analysis demonstrated a
significant interaction effect of group and sensorimotor stri-
atum DSC on ASM-thalamic iFC, suggesting that the associ-
ation between sensorimotor striatum DSC and ASM-
thalamic iFC was specific for schizophrenia. However, as
the patients recruited for this study received antipsychotic
medication, it was not possible to disentangle disorder
effects from medication effects. Specifically, both striatal
DSC and antipsychotic medication are thought to affect
postsynaptic dopaminergic receptors (McCutcheon et al.,
2020); therefore, putative downstream effects of dopamine
on neural circuits (i.e. on SAL-thalamic iFC) could be related
to disorder-specific alterations (e.g. pathologically reduced/
elevated striatal DSC) and/or effects of antipsychotic medica-
tion (e.g. by blocking dopaminergic receptors). In addition
to potential anti-dopaminergic effects of antipsychotics (and
adjunctive psychotropic medication) (see Avram et al., 2019
for discussion), anticholinergic burden of medication might
confound our results. Previous studies have demonstrated
that functional MRI-based blood oxygenation signals are
influenced by acetylcholine levels (Zaldivar et al.,2018).
However, a recent study demonstrated that although acetyl-
choline levels change the global blood oxygenation signal
(i.e. the averaged grey matter signal of blood oxygenation),
they do not seem to affect iFC of intrinsic networks such as
SAL (Turchi et al.,2018). Nevertheless, we cannot complete-
ly exclude anticholinergic effects on our findings of altered
iFC in patients, which should therefore be evaluated careful-
ly with respect to the anticholinergic burden of medication
(see Supplementary Table 1 for anticholinergic side effects of
medication in patients). Future studies could elucidate this
issue by investigating this link in unmedicated patients with
schizophrenia.
Topographic relations between
reduced striatal DSC and
cortico-thalamic dysconnectivity in
schizophrenia
In summary, our results provide evidence that decreased
striatal DSC and cortico-thalamic dysconnectivity are
topographically linked in schizophrenia: (i) within the
SAL-centred system, reduced associative striatum DSC
correlates with reduced SAL-thalamic iFC; and (ii) within
the ASM-centred system, reduced sensorimotor striatum
DSC correlates with increased ASM-thalamic iFC. We in-
terpret our findings in the framework of largely parallel
but interacting CSPTC circuits and midbrain dopamin-
ergic projections, which are both organized topographical-
ly (Alexander et al.,1986;Haber, 2003;Hikosaka et al.,
2014). Remarkably, a link integrating aberrant dopamine
transmission with CSPTC dysconnectivity in schizophre-
nia has long been proposed by theoretical models
(Swerdlow and Koob, 1987).Ourfindingsprovideempir-
ical support for such models.
However, the inherent limitations of our outcome
measures and the cross-sectional design of the study
make the translation of these statistical findings into a
full pathophysiological model difficult. First, it remains
unclear which of the two measures has a causal role in
eliciting changes in the other measure, as the direction of
influence (i.e. striatal DSC changes lead to cortico-
3502 |BRAIN 2020: 143; 3495–3505 M. Avram et al.
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
thalamic iFC alterations or vice versa) cannot be estab-
lished here, and both options seem plausible. For in-
stance, there is evidence that experimental manipulation
of dopamine transmission via pharmacological manipula-
tion influences iFC in both SAL and ASM (Cole et al.,
2013;Esposito et al., 2013;Shafiei et al., 2019).
Likewise, an influence in the other direction is also pos-
sible: cortico-thalamic iFC might alter striatal dopamine
transmission, for example via CSPTC circuits and direct
striato-nigral projections (Hikosaka et al., 2014;Haber,
2016). Therefore, a further specification of our findings
in terms of such a causal pathophysiological model
would be highly speculative. For instance, some models
propose that certain structures convey the effects of aber-
rant striatal dopamine on CSPTC circuits (e.g. ventral
pallidum) (Swerdlow and Koob, 1987); however, we are
unable to identify such possible effects with the measures
used in this study.
Second, concerning the reduction of striatal DSC under
conditions of psychotic remission, it remains unclear how
this reduction comes about—i.e. is it an effect of disorder
state or rather of antipsychotic medication, or both?
Correspondingly, although we have controlled for effects of
current medication by statistical methods, we cannot exclude
long-/mid-term effects of medication on both measures and
their relationship. Longitudinal studies investigating this re-
lationship in both medicated and unmedicated patients are
necessary to disentangle these effects.
Strengths and limitations
The current study is the first to investigate the relationship
between striatal DSC and cortico-thalamic iFC with simul-
taneous
18
F-DOPA-PET and rs-fMRI, avoiding temporal
confounds of sequential assessment. We recruited a well-
defined, homogeneous sample of patients, reducing con-
founds of symptomatic variance (i.e. psychosis); and our
results support long-established theoretical models, based on
the well-established physiological framework of CSPTC cir-
cuits. Particularly, our findings integrate two largely inde-
pendent lines of findings in schizophrenia: striatal dopamine
dysfunction and cortico-thalamic dysconnectivity. In terms
of limitations of our study, the sample size was relatively
modest, therefore findings are not definitive and have to be
evaluated carefully. Most patients were medicated, potential-
ly confounding the study’s results (Supplementary material).
For detailed discussion of this point see above. Both striatal
DSC and blood oxygenation-based cortico-thalamic iFC are
indirect measures of brain activity averaged over several
minutes and reflect mixed signals. Therefore, we are only
able to examine relatively coarse relations and we might
have missed fast-occurring effects (e.g. phasic dopaminergic
transmission).
Conclusion
Cortico-thalamic dysconnectivity links topographically with
reduced striatal dopamine in schizophrenia. Data suggest
that aberrant striatal dopamine and cortico-thalamic dyscon-
nectivity are pathophysiologically related within dopamine-
modulated cortico-basal ganglia-thalamic circuits in
schizophrenia.
Acknowledgements
We thank Sylvia Schachoff and Anna Winter for their tech-
nical assistance during PET/MRI measurements. Particularly,
we thank all subjects for participating in the study.
Funding
This work has been supported by the European Union 7th
Framework Programme, TRIMAGE, a dedicated trimodality
(PET/MR/EEG) imaging tool for schizophrenia (Grant no.
602621). F.B. was supported by the Hans und Klementia
Langmatz Stiftung. F.K. received funding from the European
Union’s Horizon 2020 (Grant number 754462).
Competing interests
The authors report no conflict of interest relating to this
work. S.L. has received honoraria for consulting or lectures
from LB Pharma, Lundbeck, Otsuka, TEVA, LTS Lohmann,
Geodon Richter, Recordati, Boehringer Ingelheim, Sandoz,
Janssen, Lilly, SanofiAventis, Servier, and Sunovion.
Supplementary material
Supplementary material is available at Brain online.
References
Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles
LS, et al. Increased baseline occupancy of D2 receptors by dopamine
in schizophrenia. Proc Natl Acad Sci USA 2000; 97: 8104–9.
Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle
M. Baseline and amphetamine-stimulated dopamine activity are
related in drug-naive schizophrenic subjects. Biol Psychiatry 2009;
65: 1091–3.
Alcauter S, Lin W, Smith JK, Short SJ, Goldman BD, Reznick JS, et al.
Development of thalamocortical connectivity during infancy and its
cognitive correlations. J Neurosci 2014; 34: 9067–75.
Alexander GE, DeLong MR, Strick PL. Parallel organization of func-
tionally segregated circuits linking basal ganglia and cortex. Annu
Rev Neurosci 1986; 9: 357–81.
Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR,
Weinberger DR. Remission in schizophrenia: proposed criteria and
rationale for consensus. Am J Psychiatry 2005; 162: 441–9.
Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, et al.
Association of thalamic dysconnectivity and conversion to psychosis
Dopamine and brain connectivity in schizophrenia BRAIN 2020: 143; 3495–3505 |3503
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
in youth and young adults at elevated clinical risk. JAMA Psychiatry
2015; 72: 882–91.
Avram M, Brandl F, Bauml J, Sorg C. Cortico-thalamic hypo- and
hyperconnectivity extend consistently to basal ganglia in schizophre-
nia. Neuropsychopharmacology 2018; 43: 2239–48.
Avram M, Brandl F, Cabello J, Leucht C, Scherr M, Mustafa M, et al.
Reduced striatal dopamine synthesis capacity in patients with schizo-
phrenia during remission of positive symptoms. Brain 2019; 142:
1813–26.
Behzadi Y, Restom K, Liau J, Liu TT. A component based noise cor-
rection method (CompCor) for BOLD and perfusion based fMRI.
Neuroimage 2007; 37: 90–101.
Bell PT, Shine JM. Subcortical contributions to large-scale network
communication. Neurosci Biobehav Rev 2016; 71: 313–22.
Berry AS, Shah VD, Jagust WJ. The influence of dopamine on cogni-
tive flexibility is mediated by functional connectivity in young but
not older adults. J Cogn Neurosci 2018; 30: 1330–44.
Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity
in the motor cortex of resting human brain using echo-planar MRI.
Magn Reson Med 1995; 34: 537–41.
Brandl F, Avram M, Weise B, Shang J, Simoes B, Bertram T, et al.
Specific substantial dysconnectivity in Schizophrenia: a transdiagnos-
tic multimodal meta-analysis of resting-state functional and struc-
tural magnetic resonance imaging studies. Biol Psychiatry 2019; 85:
573–83.
Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M,
Carlsson ML. Interactions between monoamines, glutamate, and
GABA in schizophrenia: new evidence. Annu Rev Pharmacol
Toxicol 2001; 41: 237–60.
Cole DM, Oei NY, Soeter RP, Both S, van Gerven JM, Rombouts SA,
et al. Dopamine-dependent architecture of cortico-subcortical net-
work connectivity. Cereb Cortex 2013; 23: 1509–16.
Delevich K, Tucciarone J, Huang ZJ, Li B. The mediodorsal thalamus
drives feedforward inhibition in the anterior cingulate cortex via
parvalbumin interneurons. J Neurosci 2015; 35: 5743–53.
Esposito F, Tessitore A, Giordano A, De Micco R, Paccone A,
Conforti R, et al. Rhythm-specific modulation of the sensorimotor
network in drug-naive patients with Parkinson’s disease by levo-
dopa. Brain 2013; 136: 710–25.
First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical
interview for DSM-IV-TR axis I disorders, research version, patient
edition (SCID-I/P). New York: Biometrics Research, New York State
Psychiatric Institute; 2002.
Fox MD, Raichle ME. Spontaneous fluctuations in brain activity
observed with functional magnetic resonance imaging. Nat Rev
Neurosci 2007; 8: 700–11.
Grillner S, Robertson B. The basal ganglia over 500 million years.
Curr Biol 2016; 26: R1088–R100.
Grunder G, Cumming P. The downside of downregulation. Brain
2019; 142: 1500–2.
Haber S, McFarland NR. The place of the thalamus in frontal cortical-
basal ganglia circuits. Neuroscientist 2001; 7: 315–24.
Haber SN. The primate basal ganglia: parallel and integrative net-
works. J Chem Neuroanat 2003; 26: 317–30.
Haber SN. Corticostriatal circuitry. Dialogues Clin Neurosci 2016; 18:
7–21.
Haber SN, Calzavara R. The cortico-basal ganglia integrative network:
the role of the thalamus. Brain Res Bull 2009; 78: 69–74.
Haber SN, Knutson B. The reward circuit: linking primate anatomy
and human imaging. Neuropsychopharmacology 2010; 35: 4–26.
Hietala J, Syvalahti E, Vilkman H, Vuorio K, Rakkolainen V,
Bergman J, et al. Depressive symptoms and presynaptic dopamine
function in neuroleptic-naive schizophrenia. Schizophr Res 1999;
35: 41–50.
Hikosaka O, Kim HF, Yasuda M, Yamamoto S. Basal ganglia circuits
for reward value-guided behavior. Annu Rev Neurosci 2014; 37:
289–306.
Hikosaka O, Nakamura K, Nakahara H. Basal ganglia orient eyes to
reward. J Neurophysiol 2006; 95: 567–84.
Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I,
Tabraham P, et al. Elevated striatal dopamine function linked to
prodromal signs of schizophrenia. Arch Gen Psychiatry 2009; 66:
13–20.
Howes OD, Williams M, Ibrahim K, Leung G, Egerton A, McGuire
PK, et al. Midbrain dopamine function in schizophrenia and depres-
sion: a post-mortem and positron emission tomographic imaging
study. Brain 2013; 136: 3242–51.
Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, et
al. A test of the transdiagnostic dopamine hypothesis of psychosis
using Positron Emission Tomographic imaging in bipolar affective
disorder and schizophrenia. JAMA Psychiatry 2017; 74: 1206–13.
Jauhar S, Veronese M, Nour MM, Rogdaki M, Hathway P,
Turkheimer FE, et al. Determinants of treatment response in first-
episode psychosis: an (18)F-DOPA PET study. Mol Psychiatry 2018;
24: 1502–12.
Joel D, Weiner I. The connections of the dopaminergic system with the
striatum in rats and primates: an analysis with respect to the func-
tional and compartmental organization of the striatum.
Neuroscience 2000; 96: 451–74.
Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M,
et al. Increased synaptic dopamine function in associative regions of the
striatum in schizophrenia. Arch Gen Psychiatry 2010; 67: 231–9.
Kim E, Howes OD, Veronese M, Beck K, Seo S, Park JW, et al.
Presynaptic dopamine capacity in patients with treatment-resistant
schizophrenia taking clozapine: an [(18)F]DOPA PET Study.
Neuropsychopharmacology 2017; 42: 941–50.
Lui S, Yao L, Xiao Y, Keedy SK, Reilly JL, Keefe RS, et al. Resting-
state brain function in schizophrenia and psychotic bipolar probands
and their first-degree relatives. Psychol Med 2015; 45: 97–108.
McCutcheon R, Beck K, Jauhar S, Howes OD. Defining the locus of
dopaminergic dysfunction in Schizophrenia: a meta-analysis and test
of the mesolimbic hypothesis. Schizophr Bull 2018; 44: 1301–11.
McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in
schizophrenia: biology, symptoms and treatment. World Psychiatry
2020; 19: 15–33.
McCutcheon RA, Nour MM, Dahoun T, Jauhar S, Pepper F, Expert
P, et al. Mesolimbic dopamine function is related to salience net-
work connectivity: an integrative positron emission tomography and
magnetic resonance study. Biol Psychiatry 2019; 85: 368–78.
McFarland NR, Haber SN. Thalamic relay nuclei of the basal ganglia
form both reciprocal and nonreciprocal cortical connections, linking
multiple frontal cortical areas. J Neurosci 2002; 22: 8117–32.
Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The
cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res
Rev 1995; 20: 91–127.
Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of
blood-to-brain transfer constants from multiple-time uptake data.
J Cereb Blood Flow Metab 1983; 3: 1–7.
Peters SK, Dunlop K, Downar J. Cortico-striatal-thalamic loop circuits
of the salience network: a central pathway in psychiatric disease and
treatment. Front Syst Neurosci 2016; 10: 104.
Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious
but systematic correlations in functional connectivity MRI networks
arise from subject motion. Neuroimage 2012; 59: 2142–54.
Power JD, Mitra A, Laumann TO, Snyder AZ, Schlaggar BL, Petersen
SE. Methods to detect, characterize, and remove motion artifact in
resting state fMRI. Neuroimage 2014; 84: 320–41.
Shafiei G, Zeighami Y, Clark CA, Coull JT, Nagano-Saito A, Leyton
M, et al. Dopamine signaling modulates the stability and integration
of intrinsic brain networks. Cereb Cortex 2019; 29: 397–409.
Shepherd GM, Grillner S, Handbook of brain microcircuits.2nd edn.
New York, NY: Oxford University Press; 2018.
Swerdlow N, Koob G. Dopamine, schizophrenia, mania, and depres-
sion: toward a unified hypothesis of cortico-striatopallido-thalamic
function. Behav Brain Sci 1987; 10: 197–208.
3504 |BRAIN 2020: 143; 3495–3505 M. Avram et al.
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
Tu PC, Lee YC, Chen YS, Hsu JW, Li CT, Su TP. Network-specific
cortico-thalamic dysconnection in schizophrenia revealed by intrinsic
functional connectivity analyses. Schizophr Res 2015; 166: 137–43.
Turchi J, Chang C, Ye FQ, Russ BE, Yu DK, Cortes CR, et al. The
basal forebrain regulates global resting-state fMRI fluctuations.
Neuron 2018; 97: 940–52.e4.
Varela C. Thalamic neuromodulation and its implications for executive
networks. Front Neural Circuits 2014; 8:69. doi: 10.3389/fncir.
2014.00069.
Woodward ND, Heckers S. Mapping thalamocortical functional con-
nectivity in chronic and early stages of psychotic disorders. Biol
Psychiatry 2016; 79: 1016–25.
Woodward ND, Karbasforoushan H, Heckers S. Thalamocortical dys-
connectivity in schizophrenia. Am J Psychiatry 2012; 169: 1092–9.
Wu J, Siegel B, Haier R, Buchsbaum M. Testing the Swerdlow/Koob
model of schizophrena pathophysiology using positron emission
tomography. Behav Brain Sci 1990; 13: 168–70.
Yeo BT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D,
Hollinshead M, et al. The organization of the human cerebral cortex
estimated by intrinsic functional connectivity. J Neurophysiol 2011;
106: 1125–65.
Zaldivar D, Rauch A, Logothetis NK, Goense J. Two distinct profiles
of fMRI and neurophysiological activity elicited by acetylcholine in
visual cortex. Proc Natl Acad Sci USA 2018; 115: E12073–E82.
Dopamine and brain connectivity in schizophrenia BRAIN 2020: 143; 3495–3505 |3505
Downloaded from https://academic.oup.com/brain/article/143/11/3495/5957445 by University of Cambridge user on 30 December 2020
... Moreover, they indicate that local catecholaminergic transmission in the mpFC controls DA's availability in the NAc in associative and non-associative settings. Interestingly, dysfunctional connectivity between the mpFC and NAc is considered to be a core feature of different disturbances, such as addiction, schizophrenia, depression, and Parkinson's disease [4,[28][29][30][31][32][33][34]. Moreover, findings from human studies indicate striatal DA transmission to play a paramount role in keeping the cortical-striatal-thalamic-cortical connectivity functional [29][30][31][35][36][37]. ...
... Interestingly, dysfunctional connectivity between the mpFC and NAc is considered to be a core feature of different disturbances, such as addiction, schizophrenia, depression, and Parkinson's disease [4,[28][29][30][31][32][33][34]. Moreover, findings from human studies indicate striatal DA transmission to play a paramount role in keeping the cortical-striatal-thalamic-cortical connectivity functional [29][30][31][35][36][37]. A progressive depletion of striatal DA is the hallmark of Parkinson's disease (PD). ...
Article
Full-text available
Deficits in cognitive flexibility have been characterized in affective, anxiety, and neurodegenerative disorders. This paper reviews data, mainly from studies on animal models, that support the existence of a cortical–striatal brain circuit modulated by dopamine (DA), playing a major role in cognitive/behavioral flexibility. Moreover, we reviewed clinical findings supporting misfunctioning of this circuit in Parkinson’s disease that could be responsible for some important non-motoric symptoms. The reviewed findings point to a role of catecholaminergic transmission in the medial prefrontal cortex (mpFC) in modulating DA’s availability in the nucleus accumbens (NAc), as well as a role of NAc DA in modulating the motivational value of natural and conditioned stimuli. The review section is accompanied by a preliminary experiment aimed at testing weather the extinction of a simple Pavlovian association fosters increased DA transmission in the mpFC and inhibition of DA transmission in the NAc.
... Previous studies have attempted to reveal the association between dopamine function and FST circuit connectivity using both PET and fMRI 9,[15][16][17][18] . In multimodal studies, there were associations between dopamine synthesis capacity and corticothalamic and fronto-striatal connectivity and between dopamine receptor density and striatal connectivity in schizophrenia patients 14,19,20 . However, prior investigations examined the association only for limited connections. ...
... More specifically, lower left SMA-left caudate connectivity was associated with higher NM levels. Considering that NM levels reflect dopamine function, this result is consistent with previous findings showing an association between dopamine measures and striatal connectivity in schizophrenia patients 14,19,20 . In addition, our results of the association primarily identified in the SMA-caudate connection correspond with regional characteristics. ...
Article
Full-text available
Changes in dopamine and fronto-striato-thalamic (FST) circuit functional connectivity are prominent in schizophrenia. Dopamine is thought to underlie connectivity changes, but experimental evidence for this hypothesis is lacking. Previous studies examined the association in some of the connections using positron emission tomography (PET) and functional MRI (fMRI); however, PET has disadvantages in scanning patients, such as invasiveness. Excessive dopamine induces neuromelanin (NM) accumulation, and NM-MRI is suggested as a noninvasive proxy measure of dopamine function. We aimed to investigate the association between NM and FST circuit connectivity at the network level in patients with schizophrenia. We analysed substantia nigra NM-MRI and resting-state fMRI data from 29 schizophrenia patients and 63 age- and sex-matched healthy controls (HCs). We identified the FST subnetwork with abnormal connectivity found in schizophrenia patients compared to that of HCs and investigated the relationship between constituting connectivity and NM-MRI signal. We found a higher NM signal (t = −2.12, p = 0.037) and a hypoconnected FST subnetwork (FWER-corrected p = 0.014) in schizophrenia patients than in HCs. In the hypoconnected subnetwork of schizophrenia patients, lower left supplementary motor area-left caudate connectivity was associated with a higher NM signal (β = −0.38, p = 0.042). We demonstrated the association between NM and FST circuit connectivity. Considering that the NM-MRI signal reflects dopamine function, our results suggest that dopamine underlies changes in FST circuit connectivity, which supports the dopamine hypothesis. In addition, this study reveals implications for the future use of NM-MRI in investigations of the dopamine system.
... 7 ARMS, FEP, and established schizophrenia (SCZ) together are referred to as the "schizophrenia spectrum." 3,8,9 Among various structural brain changes compared to the healthy population, abnormalities in cortico-thalamic circuits have been consistently observed in both schizophrenia [10][11][12][13][14] and in the pre-stages ARMS and FEP as well as in psychosis-spectrum youths. [15][16][17]18 Thereby, thalamic nuclei act as central hubs within these circuits, [19][20][21] suggesting that the thalamus is crucially involved in the pathophysiology of schizophrenia. ...
Article
Full-text available
Background and Hypothesis Abnormal thalamic nuclei volumes and their link to cognitive impairments have been observed in schizophrenia. However, whether and how this finding extends to the schizophrenia spectrum is unknown. We hypothesized a distinct pattern of aberrant thalamic nuclei volume across the spectrum and examined its potential associations with cognitive symptoms. Study Design We performed a FreeSurfer-based volumetry of T1-weighted brain MRIs from 137 healthy controls, 66 at-risk mental state (ARMS) subjects, 89 first-episode psychosis (FEP) individuals, and 126 patients with schizophrenia to estimate thalamic nuclei volumes of six nuclei groups (anterior, lateral, ventral, intralaminar, medial, and pulvinar). We used linear regression models, controlling for sex, age, and estimated total intracranial volume, both to compare thalamic nuclei volumes across groups and to investigate their associations with positive, negative, and cognitive symptoms. Study Results We observed significant volume alterations in medial and lateral thalamic nuclei. Medial nuclei displayed consistently reduced volumes across the spectrum compared to controls, while lower lateral nuclei volumes were only observed in schizophrenia. Whereas positive and negative symptoms were not associated with reduced nuclei volumes across all groups, higher cognitive scores were linked to lower volumes of medial nuclei in ARMS. In FEP, cognition was not linked to nuclei volumes. In schizophrenia, lower cognitive performance was associated with lower medial volumes. Conclusions Results demonstrate distinct thalamic nuclei volume reductions across the schizophrenia spectrum, with lower medial nuclei volumes linked to cognitive deficits in ARMS and schizophrenia. Data suggest a distinctive trajectory of thalamic nuclei abnormalities along the course of schizophrenia.
... [40][41][42][43][44][45][46][47] Aberrant FC within the cortico-striato-pallido-thalamo-cortical circuit is assumed to be modulated by schizophrenia-related striatal dopamine dysfunction. 81 Striatal dopamine dysfunction is seen as the interface between the dopamine, glutamate, and serotonin hypothesis of psychosis. 82 In particular, hypofunctional NMDA receptors in the prefrontal cortex and hyperactivated cortical 5-HT 2A receptors are assumed to impair downstream glutamate signaling which in turn is considered to cause an overactivation of striatal dopamine synapses. ...
Article
Background and hypothesis: Aerobic exercise interventions in people with schizophrenia have been demonstrated to improve clinical outcomes, but findings regarding the underlying neural mechanisms are limited and mainly focus on the hippocampal formation. Therefore, we conducted a global exploratory analysis of structural and functional neural adaptations after exercise and explored their clinical implications. Study design: In this randomized controlled trial, structural and functional MRI data were available for 91 patients with schizophrenia who performed either aerobic exercise on a bicycle ergometer or underwent a flexibility, strengthening, and balance training as control group. We analyzed clinical and neuroimaging data before and after 6 months of regular exercise. Bayesian linear mixed models and Bayesian logistic regressions were calculated to evaluate effects of exercise on multiple neural outcomes and their potential clinical relevance. Study results: Our results indicated that aerobic exercise in people with schizophrenia led to structural and functional adaptations mainly within the default-mode network, the cortico-striato-pallido-thalamo-cortical loop, and the cerebello-thalamo-cortical pathway. We further observed that volume increases in the right posterior cingulate gyrus as a central node of the default-mode network were linked to improvements in disorder severity. Conclusions: These exploratory findings suggest a positive impact of aerobic exercise on 3 cerebral networks that are involved in the pathophysiology of schizophrenia. Clinical trials registration: The underlying study of this manuscript was registered in the International Clinical Trials Database, ClinicalTrials.gov (NCT number: NCT03466112, https://clinicaltrials.gov/ct2/show/NCT03466112?term=NCT03466112&draw=2&rank=1) and in the German Clinical Trials Register (DRKS-ID: DRKS00009804).
... In its original conception, this model aimed to explain the action of not only psychedelics but also other substances (e.g., ketamine) and endogenous psychosis (11). In support of such a hypothesis, a link between dopamine synthesis capacity and thalamocortical dysconnectivity has been reported in patients with schizophrenia (14). Regarding the specific mechanism of psychedelics, the model is supported by several lines of evidence, including human in vivo neuroimaging (7,12). ...
Article
Full-text available
Background: While the exploration of serotonergic psychedelics as psychiatric medicines deepens, so does the pressure to better understand how these compounds act on the brain. Methods: We used a double-blind, placebo-controlled, crossover design and administered lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), and d-amphetamine in 25 healthy participants. By employing spectral dynamic causal modeling, we mapped substance-induced changes in effective-connectivity between the thalamus and different cortex types (unimodal vs. transmodal) derived from a previous study in resting-state functional magnetic resonance imaging (fMRI) data. Due to the distinct pharmacological modes of action of the three substances, we were able to investigate specific effects mainly driven by different neurotransmitter systems on thalamocortical and corticothalamic interactions. Results: Compared to placebo, all three substances increased the effective-connectivity from the thalamus to specific unimodal cortices, whereas the influence of these cortices on the thalamus was reduced. These results indicate increased bottom-up and decreased top-down information flow between the thalamus and some unimodal cortices. However, for the amphetamines, we found the opposite effects when examining the effective-connectivity with transmodal cortices, covering parts of the salience network. Intriguingly, LSD increased the effective-connectivity from the thalamus to both unimodal and transmodal cortices, indicating a breach in the hierarchical organization of ongoing brain activity. Conclusion: Results advance our knowledge concerning the action of psychedelics on the brain and refine current models aiming to explain the underlying neurobiological processes.
Article
Background A better understanding of the mechanisms underlying cognitive impairment in schizophrenia is imperative, as it causes poor functional outcomes and a lack of effective treatments. Aims This study aimed to investigate the relationships of two proposed main pathophysiology of schizophrenia, altered prefrontal–striatal connectivity and the dopamine system, with cognitive impairment and their interactions. Methods Thirty-three patients with schizophrenia and 27 healthy controls (HCs) who are right-handed and matched for age and sex were recruited. We evaluated their cognition, functional connectivity (FC) between the dorsolateral prefrontal cortex (DLPFC)/middle frontal gyrus (MiFG) and striatum, and the availability of striatal dopamine transporter (DAT) using a cognitive battery investigating attention, memory, and executive function, resting-state functional magnetic resonance imaging with group independent component analysis and single-photon emission computed tomography with 99mTc-TRODAT. Results Patients with schizophrenia exhibited poorer cognitive performance, reduced FC between DLPFC/MiFG and the caudate nucleus (CN) or putamen, decreased DAT availability in the left CN, and decreased right–left DAT asymmetry in the CN compared to HCs. In patients with schizophrenia, altered imaging markers are associated with cognitive impairments, especially the relationship between DLPFC/MiFG–putamen FC and attention and between DAT asymmetry in the CN and executive function. Conclusions This study is the first to demonstrate how prefrontal–striatal hypoconnectivity and altered striatal DAT markers are associated with different domains of cognitive impairment in schizophrenia. More research is needed to evaluate their complex relationships and potential therapeutic implications.
Article
Prominent pathological hypotheses for schizophrenia include auditory processing deficits and dysconnectivity within cerebral networks. However, most neuroimaging studies have focused on impairments in either resting‐state or task‐related functional connectivity in patients with schizophrenia. The aims of our study were to examine (1) blood oxygen level‐dependent (BOLD) signals during auditory steady‐state response (ASSR) tasks, (2) functional connectivity during the resting‐state and ASSR tasks and (3) state shifts between the resting‐state and ASSR tasks in patients with schizophrenia. To reduce the functional consequences of scanner noise, we employed resting‐state and sparse sampling auditory fMRI paradigms in 25 schizophrenia patients and 25 healthy controls. Auditory stimuli were binaural click trains at frequencies of 20, 30, 40 and 80 Hz. Based on the detected ASSR‐evoked BOLD signals, we examined the functional connectivity between the thalamus and bilateral auditory cortex during both the resting state and ASSR task state, as well as their alterations. The schizophrenia group exhibited significantly diminished BOLD signals in the bilateral auditory cortex and thalamus during the 80 Hz ASSR task (corrected p < 0.05). We observed a significant inverse relationship between the resting state and ASSR task state in altered functional connectivity within the thalamo‐auditory network in schizophrenia patients. Specifically, our findings demonstrated stronger functional connectivity in the resting state ( p < 0.004) and reduced functional connectivity during the ASSR task ( p = 0.048), which was mediated by abnormal state shifts, within the schizophrenia group. These results highlight the presence of abnormal thalamocortical connectivity associated with deficits in the shift between resting and task states in patients with schizophrenia.
Article
Full-text available
The role of the thalamus in mediating the effects of lysergic acid diethylamide (LSD) was recently proposed in a model of communication and corroborated by imaging studies. However, a detailed analysis of LSD effects on nuclei-resolved thalamocortical connectivity is still missing. Here, in a group of healthy volunteers, we evaluated whether LSD intake alters the thalamocortical coupling in a nucleus-specific manner. Structural and resting-state functional Magnetic Resonance Imaging (MRI) data were acquired in a placebo-controlled study on subjects exposed to acute LSD administration. Structural MRI was used to parcel the thalamus into its constituent nuclei based on individual anatomy. Nucleus-specific changes of resting-state functional MRI (rs-fMRI) connectivity were mapped using a seed-based approach. LSD intake selectively increased the thalamocortical functional connectivity (FC) of the ventral complex, pulvinar, and non-specific nuclei. Functional coupling was increased between these nuclei and sensory cortices that include the somatosensory and auditory networks. The ventral and pulvinar nuclei also exhibited increased FC with parts of the associative cortex that are dense in serotonin type 2A receptors. These areas are hyperactive and hyper-connected upon LSD intake. At subcortical levels, LSD increased the functional coupling among the thalamus's ventral, pulvinar, and non-specific nuclei, but decreased the striatal-thalamic connectivity. These findings unravel some LSD effects on the modulation of subcortical-cortical circuits and associated behavioral outputs.
Preprint
Full-text available
Changes in dopamine and fronto-striato-thalamic (FST) circuit functional connectivity are prominent in schizophrenia. Dopamine is thought to underlie connectivity changes, but experimental evidence for this hypothesis is lacking. Previous studies examined the association in some of the connections using positron emission tomography (PET) and functional MRI (fMRI); however, PET has disadvantages in scanning patients, such as invasiveness. Excessive dopamine induces neuromelanin (NM) accumulation, and NM-MRI is suggested as a noninvasive proxy measure of dopamine function. We aimed to investigate the association between NM and FST circuit connectivity at the network level in patients with schizophrenia. We analysed substantia nigra NM-MRI and resting-state fMRI data from 29 schizophrenia patients and 63 age- and sex-matched healthy controls (HCs). We identified the FST subnetwork with abnormal connectivity found in schizophrenia patients compared to that of HCs and investigated the relationship between constituting connectivity and NM. We found higher levels of NM (t = -2.12, p = 0.037) and a hypoconnected FST subnetwork (FWER-corrected p = 0.014) in schizophrenia patients than in HCs. In the hypoconnected subnetwork of schizophrenia patients, lower left supplementary motor area-left caudate connectivity was associated with higher NM levels (β = -0.38, p = 0.042). We demonstrated the association between NM and FST circuit connectivity. Considering that the NM-MRI signal reflects dopamine activity, our results suggest that dopamine underlies changes in FST circuit connectivity, which supports the dopamine hypothesis. In addition, this study reveals implications for the future use of NM-MRI in investigations of the dopamine system.
Article
Full-text available
Glutamate and dopamine systems play distinct roles in terms of neuronal signalling, yet both have been proposed to contribute significantly to the pathophysiology of schizophrenia. In this paper we assess research that has implicated both systems in the aetiology of this disorder. We examine evidence from post‐mortem, preclinical, pharmacological and in vivo neuroimaging studies. Pharmacological and preclinical studies implicate both systems, and in vivo imaging of the dopamine system has consistently identified elevated striatal dopamine synthesis and release capacity in schizophrenia. Imaging of the glutamate system and other aspects of research on the dopamine system have produced less consistent findings, potentially due to methodological limitations and the heterogeneity of the disorder. Converging evidence indicates that genetic and environmental risk factors for schizophrenia underlie disruption of glutamatergic and dopaminergic function. However, while genetic influences may directly underlie glutamatergic dysfunction, few genetic risk variants directly implicate the dopamine system, indicating that aberrant dopamine signalling is likely to be predominantly due to other factors. We discuss the neural circuits through which the two systems interact, and how their disruption may cause psychotic symptoms. We also discuss mechanisms through which existing treatments operate, and how recent research has highlighted opportunities for the development of novel pharmacological therapies. Finally, we consider outstanding questions for the field, including what remains unknown regarding the nature of glutamate and dopamine function in schizophrenia, and what needs to be achieved to make progress in developing new treatments.
Article
Full-text available
While there is consistent evidence for increased presynaptic dopamine synthesis capacity in the striatum of patients with schizophrenia during psychosis, it is unclear whether this also holds for patients during psychotic remission. This study investigates whether striatal dopamine synthesis capacity is altered in patients with schizophrenia during symptomatic remission of positive symptoms, and whether potential alterations relate to symptoms other than positive, such as cognitive difficulties. Twenty-three patients with schizophrenia in symptomatic remission of positive symptoms according to Andreasen, and 24 healthy controls underwent 18F-DOPA-PET and behavioural-cognitive assessment. Imaging data were analysed with voxel-wise Patlak modelling with cerebellum as reference region, resulting in the influx constant kicer reflecting dopamine synthesis capacity. For the whole striatum and its subdivisions (i.e. limbic, associative, and sensorimotor), averaged regional kicer values were calculated, compared across groups, and correlated with behavioural-cognitive scores, including a mediation analysis. Patients had negative symptoms (Positive and Negative Syndrome Scale-negative 14.13 ± 5.91) and cognitive difficulties, i.e. they performed worse than controls in Trail-Making-Test-B (TMT-B; P = 0.01). Furthermore, kicer was reduced in patients for whole striatum (P = 0.004) and associative (P = 0.002) and sensorimotor subdivisions (P = 0.007). In patients, whole striatum kicer was negatively correlated with TMT-B (rho = -0.42, P = 0.04; i.e. the lower striatal kicer, the worse the cognitive performance). Mediation analysis showed that striatal kicer mediated the group difference in TMT-B. Results demonstrate that patients with schizophrenia in symptomatic remission of positive symptoms have decreased striatal dopamine synthesis capacity, which mediates the disorder's impact on cognitive difficulties. Data suggest that striatal dopamine dysfunction contributes to cognitive difficulties in schizophrenia.
Article
Full-text available
Significance fMRI changes are typically assumed to be due to changes in neural activity, although whether this remains valid under the influence of neuromodulators is relatively unknown. Here, we found evidence that intracortical acetylcholine elicits distinct profiles of fMRI and electrophysiological activity in visual cortex. Two patterns of cholinergic activity were observed, depending on the distance to the injection site, although neurovascular coupling was preserved. Our results illustrate the effects of neuromodulators on fMRI and electrophysiological responses and show that these depend on neuromodulator concentration and kinetics.
Article
Full-text available
BACKGROUND: A wide range of neuropsychiatric disorders, from schizophrenia to drug addiction, involve abnormalities in both the mesolimbic dopamine system and the cortical salience network. Both systems play a key role in the detection of behaviorally relevant environmental stimuli. Although anatomical overlap exists, the functional relationship between these systems remains unknown. Preclinical research has suggested that the firing of mesolimbic dopamine neurons may activate nodes of the salience network, but in vivo human research is required given the species-specific nature of this network. METHODS: We employed positron emission tomography to measure both dopamine release capacity (using the D2/3 receptor ligand 11C-PHNO, n = 23) and dopamine synthesis capacity (using 18F-DOPA, n = 21) within the ventral striatum. Resting-state functional magnetic resonance imaging was also undertaken in the same individuals to investigate salience network functional connectivity. A graph theoretical approach was used to characterize the relationship between dopamine measures and network connectivity. RESULTS: Dopamine synthesis capacity was associated with greater salience network connectivity, and this relationship was particularly apparent for brain regions that act as information-processing hubs. In contrast, dopamine release capacity was associated with weaker salience network connectivity. There was no relationship between dopamine measures and visual and sensorimotor networks, indicating specificity of the findings. CONCLUSIONS: Our findings demonstrate a close relationship between the salience network and mesolimbic dopamine system, and they are relevant to neuropsychiatric illnesses in which aberrant functioning of both systems has been observed.
Article
Full-text available
Background: A wide range of neuropsychiatric disorders, from schizophrenia to drug addiction, involve abnormalities in both the mesolimbic dopamine system and the cortical salience network. Both systems play a key role in the detection of behaviorally relevant environmental stimuli. Although anatomical overlap exists, the functional relationship between these systems remains unknown. Preclinical research has suggested that the firing of mesolimbic dopamine neurons may activate nodes of the salience network, but in vivo human research is required given the species-specific nature of this network. Methods: We employed positron emission tomography to measure both dopamine release capacity (using the D2/3 receptor ligand 11C-PHNO, n = 23) and dopamine synthesis capacity (using 18F-DOPA, n = 21) within the ventral striatum. Resting-state functional magnetic resonance imaging was also undertaken in the same individuals to investigate salience network functional connectivity. A graph theoretical approach was used to characterize the relationship between dopamine measures and network connectivity. Results: Dopamine synthesis capacity was associated with greater salience network connectivity, and this relationship was particularly apparent for brain regions that act as information-processing hubs. In contrast, dopamine release capacity was associated with weaker salience network connectivity. There was no relationship between dopamine measures and visual and sensorimotor networks, indicating specificity of the findings. Conclusions: Our findings demonstrate a close relationship between the salience network and mesolimbic dopamine system, and they are relevant to neuropsychiatric illnesses in which aberrant functioning of both systems has been observed.
Article
Full-text available
Dopaminergic signaling in striatum is strongly implicated in executive functions including cognitive flexibility. However, there is a paucity of multimodal research in humans defining the nature of relationships between endogenous dopamine, striatal network activity, and cognition. Here, we measured dopamine synthesis capacity in young and older adults using the PET tracer 6-[18F]fluoro-l- m-tyrosine and examined its relationship with cognitive performance and functional connectivity during an fMRI study of task switching. Aging is associated with alteration in dopamine function, including profound losses in dopamine receptors but an apparent elevation in dopamine synthesis. A compensatory benefit of upregulated dopamine synthesis in aging has not been established. Across young and older adults, we found that cognitive flexibility (low behavioral switch cost) was associated with stronger task-related functional connectivity within canonical fronto-striato-thalamic circuits connecting left inferior frontal gyrus, dorsal caudate nucleus (DCA) and ventral lateral/ventral anterior thalamic nuclei. In young adults, functional connectivity mediated the influence of DCA dopamine synthesis capacity on switch cost. For older adults, these relationships were modified such that DCA synthesis capacity and connectivity interacted to influence switch cost. Older adults with most elevated synthesis capacity maintained the pattern of connectivity-cognition relationships observed in youth, whereas these relationships were not evident for older adults with low synthesis capacity. Together, these findings suggest a role of dopamine in tuning striatal circuits to benefit executive function in young adults and clarify the functional impact of elevated dopamine synthesis capacity in aging.
Article
Microcircuits are the specific arrangements of cells and their connections that carry out the operations unique to each brain region. This resource summarizes succinctly these circuits in over 40 regions - enabling comparisons of principles across both vertebrates and invertebrates. It provides a new foundation for understanding brain function that will be of interest to all neuroscientists.
Article
Background: This study investigated characteristic large-scale brain changes in schizophrenia. Numerous imaging studies have demonstrated brain changes in schizophrenia, particularly aberrant intrinsic functional connectivity (iFC) of ongoing brain activity, measured by resting-state functional magnetic resonance imaging, and aberrant gray matter volume (GMV) of distributed brain regions, measured by structural magnetic resonance imaging. It is unclear, however, which iFC changes are specific to schizophrenia compared with those of other disorders and whether such specific iFC changes converge with GMV changes. To address this question of specific substantial dysconnectivity in schizophrenia, we performed a transdiagnostic multimodal meta-analysis of resting-state functional and structural magnetic resonance imaging studies in schizophrenia and other psychiatric disorders. Methods: Multiple databases were searched up to June 2017 for whole-brain seed-based iFC studies and voxel-based morphometry studies in schizophrenia, major depressive disorder, bipolar disorder, addiction, and anxiety. Coordinate-based meta-analyses were performed to detect 1) schizophrenia-specific hyperconnectivity or hypoconnectivity of intrinsic brain networks (compared with hyperconnectivity or hypoconnectivity of each other disorder both separately and combined across comparisons) and 2) the overlap between dysconnectivity and GMV changes (via multimodal conjunction analysis). Results: For iFC meta-analysis, 173 publications comprising 4962 patients and 4575 control subjects were included, and for GMV meta-analysis, 127 publications comprising 6311 patients and 6745 control subjects were included. Disorder-specific iFC dysconnectivity in schizophrenia (consistent across comparisons with other disorders) was found for limbic, frontoparietal executive, default mode, and salience networks. Disorder-specific dysconnectivity and GMV reductions converged in insula, lateral postcentral cortex, striatum, and thalamus. Conclusions: Results demonstrated specific substantial dysconnectivity in schizophrenia in insula, lateral postcentral cortex, striatum, and thalamus. Data suggest that these regions are characteristic targets of schizophrenia.
Article
Dopaminergic projections are hypothesized to stabilize neural signaling and neural representations, but how they shape regional information processing and large-scale network interactions remains unclear. Here we investigated effects of lowered dopamine levels on within-region temporal signal variability (measured by sample entropy) and between-region functional connectivity (measured by pairwise temporal correlations) in the healthy brain at rest. The acute phenylalanine and tyrosine depletion (APTD) method was used to decrease dopamine synthesis in 51 healthy participants who underwent resting-state functional MRI (fMRI) scanning. Functional connectivity and regional signal variability were estimated for each participant. Multivariate partial least squares (PLS) analysis was used to statistically assess changes in signal variability following APTD as compared with the balanced control treatment. The analysis captured a pattern of increased regional signal variability following dopamine depletion. Changes in hemodynamic signal variability were concomitant with changes in functional connectivity, such that nodes with greatest increase in signal variability following dopamine depletion also experienced greatest decrease in functional connectivity. Our results suggest that dopamine may act to stabilize neural signaling, particularly in networks related to motor function and orienting attention towards behaviorally-relevant stimuli. Moreover, dopamine-dependent signal variability is critically associated with functional embedding of individual areas in large-scale networks.